Evidence map›Paper›PMID 31870406›Full record

ArticleParasites & vectors2019

In vitro activity of 1H-phenalen-1-one derivatives against Leishmania spp. and evidence of programmed cell death.

Atteneri López-Arencibia, María Reyes-Batlle, Mónica B Freijo, Ines Sifaoui, Carlos J Bethencourt-Estrella, Aitor Rizo-Liendo, Olfa Chiboub, Grant McNaughton-Smith, Jacob Lorenzo-Morales, Teresa Abad-Grillo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Meroterpenoids fromPharmaceuticals (Basel, Switzerland) · 2023
    Article
  2. Discovery of New Chemical Tools againstPharmaceuticals (Basel, Switzerland) · 2021
    Article
  3. Article
  4. Phytotoxicity ofMolecules (Basel, Switzerland) · 2021
    Article
  5. Acrylonitrile Derivatives againstPharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Atteneri López-ArencibiaInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain. atlopez@ull.edu.es.
María Reyes-BatlleInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain.
Mónica B FreijoInstituto Universitario de Bio-Orgánica 'Antonio González', Departamento de Química Orgánica, Universidad de La Laguna, Avda. Fco. Sánchez 2, 38206, La Laguna, Tenerife, Islas Canarias, Spain.
Ines SifaouiInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain.
Carlos J Bethencourt-EstrellaInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain.
Aitor Rizo-LiendoInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain.
Olfa ChiboubInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain.
Grant McNaughton-SmithCentro Atlántico del Medicamento S.A (CEAMED S.A.), PCTT, La Laguna, Tenerife, Islas Canarias, Spain.
Jacob Lorenzo-MoralesInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain.
Teresa Abad-GrilloInstituto Universitario de Bio-Orgánica 'Antonio González', Departamento de Química Orgánica, Universidad de La Laguna, Avda. Fco. Sánchez 2, 38206, La Laguna, Tenerife, Islas Canarias, Spain.
José E PiñeroInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203, La Laguna, Tenerife, Islas Canarias, Spain. jpinero@ull.edu.es.
Hospital Universitario de Canarias · ESUniversidad de La Laguna · ES

Funding

PREVENTIVE ONCOLOGY ACADEMIC AWARDK07CA001380 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILCHREST, BARBARA A · 1988 to 1992
–
Ministerio de Ciencia, Innovación y Universidades PI18/01380Ministerio de Ciencia, Innovación y Universidades RD16/0027/0001
6 · The paper itself

Abstract

backgroundThe in vitro activity against Leishmania spp. of a novel group of compounds, phenalenone derivatives, is described in this study. Previous studies have shown that some phenalenones present leishmanicidal activity, and induce a decrease in the mitochondrial membrane potential in L. amazonensis parasites, so in order to elucidate the evidence of programmed cell death occurring inside the promastigote stage, different assays were performed in two different species of Leishmania.

methodsWe focused on the determination of the programmed cell death evidence by detecting the characteristic features of the apoptosis-like process, such as phosphatidylserine exposure, mitochondrial membrane potential, and chromatin condensation among others.

resultsThe results showed that four molecules activated the apoptosis-like process in the parasite. All the signals observed were indicative of the death process that the parasites were undergoing.

conclusionsThe present results highlight the potential use of phenalenone derivatives against Leishmania species and further studies should be undertaken to establish them as novel leishmanicidal therapeutic agents.

Indexed as

Antiprotozoal AgentsApoptosisHumansLeishmaniaLeishmaniasisLife Cycle StagesMolecular StructurePhenalenesAntiprotozoal Agentsphenalen-1-onePhenalenesApoptosis-likeChemotherapyLeishmania amazonensisLeishmania donovaniPhenalenones

Identifiers

PMID31870406
PMCPMC6929359
OpenAlexW2997158867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.